Skip to content
Recall Observatory FDA recall evidence

Device product

Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing), CE marked

Z-0945-2022

January 09, 2022

Class II

Product summary

Firm
Acon Biotech (Hangzhou) Co., Ltd.
Event
Event 89755
Status
Ongoing
Classification
Class II
Quantity
303,760
Official record key
device-enforcement:Z-0945-2022

Official wording

Reason: Non-EUA authorized, CE marked, SARS-CoV-2 antigen rapid test kits are being recalled from the U.S. market because use may lead to inaccurate test results, including false negative or false positive test results.

Code information: Lots: COV1080201, COV1105014

Distribution pattern: US: MD, PA International Distribution to countries of: Hungary and China.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Non-EUA authorized, CE marked, SARS-CoV-2 antigen rapid test kits are being recalled from the U.S. market because use may lead to inaccurate test results, including false negative or false positive test results.

Field note

Send feedback

We'll only use this to respond to your feedback.